The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review.
The role of radionuclide probes for monitoring anti-tumor drugs efficacy: A brief review.
复制标题
DOI:
10.1016/j.biopha.2017.08.079
复制
发表时间:
2017-11
期刊:
影响因子:
--
通讯作者:
de Barros ALB
中科院分区:
文献类型:
--
作者:
Fernandes RS;de Aguiar Ferreira C;Soares DCF;Maffione AM;Townsend DM;Rubello D;de Barros ALB
Despite recent advances in the development of new therapeutic agents and diagnostic imaging modalities, cancer is still one of the main causes of death worldwide. A better understanding of the molecular signature of cancer has promoted the development of a new generation of anti-cancer drugs and diagnostic agents that specifically target molecular components such as genes, ligands, receptors and signaling pathways. However, intrinsic heterogeneity of tumors has hampered the overall success of target therapies even among patients with similar tumor types but unpredictable different responses to therapy. In this sense, post-treatment response monitoring becomes indispensable and nuclear medicine imaging modalities could provide the tools for an early indication of therapeutic efficacy. Herein, we briefly discuss the current role of PET and SPECT imaging in monitoring cancer therapy together with an update on the current radiolabeled probes that are currently investigated for tumor therapy response assessment.
登录
查看更多内容
影响因子:
--
作者:
Niccoli Asabella A;Cascini GL;Altini C;Paparella D;Notaristefano A;Rubini G
通讯作者:
Rubini G
影响因子:
4.9
作者:
Beaino W;Nedrow JR;Anderson CJ
通讯作者:
Anderson CJ
影响因子:
0.9
作者:
Artiko, Vera;Afgan, Aida;Obradovic, Vladimir
通讯作者:
Obradovic, Vladimir
影响因子:
2.8
作者:
Aung W;Tsuji AB;Sudo H;Sugyo A;Furukawa T;Ukai Y;Kurosawa Y;Saga T
通讯作者:
Saga T
DOI:
10.1007/s00259-017-3728-y
发表时间:
2017-08-01
影响因子:
9.1
作者:
Bozkurt, Murat Fani;Virgolini, Irene;Fanti, Stefano
通讯作者:
Fanti, Stefano